RMD
ResMed Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -11.1% ·
share flow -5.5% ·
net new positions -12.5%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +2 | 76.69M | $14.96B | +7 | −4 |
| Q1 2026 | 159 | +3 | 74.11M | $16.62B | +5 | −3 |
| Q4 2025 | 155 | -2 | 83.70M | $20.16B | +1 | −2 |
| Q3 2025 | 21 | 0 | 49.43M | $13.53B | — | −1 |
| Q2 2025 | 19 | +1 | 44.83M | $11.56B | +1 | — |
| Q1 2025 | 15 | -1 | 12.96M | $2.90B | — | −1 |
| Q4 2024 | 16 | -2 | 12.69M | $2.90B | — | −2 |
| Q3 2024 | 17 | +2 | 6.96M | $1.70B | +2 | — |
| Q2 2024 | 15 | — | 5.93M | $1.13B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 6.47M | — | $1.48B | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.94M | +2.2% | $899.86M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.94M | +2.2% | $899.86M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 625.05K | +133.6% | $142.94M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 625.05K | +133.6% | $142.94M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 625.05K | +133.6% | $142.94M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 625.05K | +133.6% | $142.94M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 625.05K | +133.6% | $142.94M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 625.05K | +133.6% | $142.94M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passive) | 518.63K | +8.2% | $118.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 310.97K | +0.8% | $71.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 310.97K | +0.8% | $71.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 247.70K | +194.9% | $56.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 216.13K | +9.1% | $49.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 107.48K | -53.2% | $24.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 87.27K | -7.1% | $19.96M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 46.54K | +306.9% | $10.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 43.03K | +61.0% | $9.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 25.88K | -44.3% | $5.92M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 24.83K | -93.6% | $5.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 8.96K | -85.0% | $2.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 8.96K | -85.0% | $2.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 7.85K | -98.0% | $1.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 6.55K | -57.1% | $1.50M | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Coatue Management | $115.51M | was 0.4% |
| Baillie Gifford | $3.78M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 932 holders, 96.37M shares, $21.06B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 4.99K sh · $1.03M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology